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Abstract
Background:  The National Institute of Diabetes and Digestive and Kidney Diseases have
established central repositories for the collection of DNA, biological samples, and clinical data to
be catalogued at a single site. Here we present an overview of the site which stores the clinical data
and links to biospecimens.
Description: The NIDDK Data repository is a web-enabled resource cataloguing clinical trial data
and supporting information from NIDDK supported studies. The Data Repository allows for the
co-location of multiple electronic datasets that were created as part of clinical investigations. The
Data Repository does not serve the role of a Data Coordinating Center, but rather as a warehouse
for the clinical findings once the trials have been completed. Because both biological and genetic
samples are collected from many of the studies, a data management system for the cataloguing and
retrieval of samples was developed.
Conclusion: The Data Repository provides a unique resource for researchers in the clinical areas
supported by NIDDK. In addition to providing a warehouse of data, Data Repository staff work
with the users to educate them on the datasets as well as assist them in the acquisition of multiple
data sets for cross-study analysis. Unlike the majority of biological databases, the Data Repository
acts both as a catalogue for data, biosamples, and genetic materials and as a central processing point
for the requests for all biospecimens. Due to regulations on the use of clinical data, the ultimate
release of that data is governed under NIDDK data release policies. The Data Repository serves
as the conduit for such requests.
Background
The National Institute of Diabetes and Digestive and Kid-
ney Diseases (NIDDK) of the National Institutes of Health
(NIH), part of the U.S. Department of Health and Human
Services, have established central repositories for DNA,
biospecimens, and data collected in clinical studies. The
purpose of the Central Repositories is to increase the util-
ity of NIDDK sponsored research by providing access to
the samples and data to a wider research community than
those research groups involved in the studies.
The repositories involved in this initiative are:
Data repository [1]
Research Triangle Institute (RTI International)
Research Triangle Park, NC
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Biosample repository [2]
McKesson Bioservice Corporations (Now Fisher Bioserv-
ices)
Rockville, MD
Genetic (DNA) repository [3]
Rutgers University Cell and DNA Repository
Piscataway, NJ
It is the responsibility of the Data Repository to maintain
the linkage of all biological materials to the appropriate
clinical data. For ongoing studies, which have not yet
released their data, the Data Repository provides the
appropriate identifiers to the study coordinators and the
specimen repositories in order to create unambiguous
linkages between specimens and data.
Datasets
As of November 2005, the Data Repository contains data
from six completed studies. We also anticipate the availa-
bility of an additional five data sets (HEMO, DPP, Vira-
hep-C, EDIC, and CRISP) during 2006. The data sets
presently available are:
Liver Transplant Database (LTD) [4,5]
Information collected in a sever-year prospective study of
916 liver transplant recipients out of 1563 candidates.
Liver Transplant Database Follow-up (LTD2) [4,5]
Long-term follow-up information for the original cohort
of liver transplant recipients in the LDT database.
National Analgesic Nephropathy Study (NANS) [6]
Information on the relationship between analgesic use
and end-stage renal disease.
Diabetes Prevention Type 1 Study (DPT-1) [7,8]
Information on the effects of treatment with beta-cell anti-
gens on the onset of Type 1 Diabetes Mellitus.
Modification of Diet in Renal Disease (MDRD) [9]
Cooperative study results on the effects of dietary protein
and phosphorous and/or reduction of blood pressure and
the rate of progression of chronic renal disease.
Interstitial Cystitis Data Base (ICDB) [10]
Prospective, longitudinal, multi-center study results of
various patient treatments on Interstitial Cystitis.
Construction and content
Catalogue
For all data available through the Data Repository, a cata-
logue entry is maintained. The purpose is to describe to
the potential user the data contained in each dataset. It is
important that the user have a clear understanding of the
datasets because the procedure of requesting data requires
the expenditures of time and resources of sources such as
an IRB (Institutional Review Board) and examination and
approval by both the requestor's organization and
NIDDK.
The following information, where available, about each
dataset is reported on the web:
General description
Abstract discussing the study.
Manuals of operations/protocols
Procedures used in collecting clinical data.
Forms
Examples of all the forms used in collecting clinical data.
Data description
Detailed listing of the data available from the study,
including SAS variable descriptions.
Publications
Links to publications resulting from the clinical studies.
Figure 1 shows a sample of information available on two
datasets.
In addition to the raw data, Data Repository staff work
with the studies to develop meta-data descriptions for the
data sets. These data include information such as the
demographics of the patients, population size, sample
availability, and medical tests performed.
Utility
This information is useful for researchers who may wish
to obtain data sets in order to perform meta-studies. One
example might be a researcher looking to compare certain
clinical data such as creatinine levels over multiple treat-
ments in different studies. An examination of the meta-
data would be a first step for the user to determine
whether enough information could be obtained from
multiple datasets in order to perform a statistically valid
analysis.
Data requests and release
Datasets are provided on CD-ROM. Because of both data-
set size and health data security, primary data is not made
available through the web. While the datasets are consid-
ered to be "limited-use" and exempt from HIPAA, because
the data contains patient information (albeit anony-
mous) it must be treated securely. The NIDDK repository
follows the guidelines as specified in the document –BMC Medical Informatics and Decision Making 2006, 6:19 http://www.biomedcentral.com/1472-6947/6/19
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Research Repositories, databases and the HIPAA privacy rule
[11]. Additionally, the Data Repository provides informa-
tion on available biological specimens.
Researchers requesting data generally contact the Data
Repository to discuss the data sets in more detail. In cases
where researchers may wish to obtain data from multiple
studies to use for meta-analyses, Data Repository staff
work with them to create custom summaries and record
counts to determine usefulness. This service is generally
provided free or charge, however a nominal fee may be
incurred for significant work. Figure 2 show a flow-chart
of the data request and release process.
A sample of the listing of currently data available Figure 1
A sample of the listing of currently data available. By selecting the tags to the right of the study abstract, users can obtain more 
detailed listing on the study.BMC Medical Informatics and Decision Making 2006, 6:19 http://www.biomedcentral.com/1472-6947/6/19
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When data are received at the Data Repository, the data
undergo an initial review for the assignment of meta-data.
The variables in the data sets (generally SAS data) are
related to the clinical report forms. During this process a
spreadsheet is kept which relate the variables from multi-
ple data sets which are identical measurements. These
spreadsheets are used by Data Repository staff as the start-
ing point for answering questions about aggregating data
sets. As information is determined through a more vigor-
ous custom analysis, those data are reflected in the spread-
sheets. Tools will be constructed as needed for Data
Repository staff to automate this process where feasible.
These analyses are performed by internal staff and not
data requestors due to the nature of the data privacy. For
requestors to perform such analyses would require them
to have data use approval for every data set queried in the
process. A fee schedule is available at the Data Repository
site for these analyses. The work is performed on a cost-
recovery basis after an initial analysis.
Once a researcher has determined that the data set(s)
meets his/her need, a request for data release is sent to
NIDDK for review. NIDDK has developed a panel of
reviewers with research experience to conduct these
reviews. This review is required for the release of patient
data and requires an IRB approval from the requestor's
organization and a signed data use agreement specifying
the conditions under which the data are to be stored, ana-
lyzed and protected. Once approved, the Data Repository
prepares the data for release and CD-ROMs are created
and mailed. The CD-ROMs, in general, will contain the
complete data for all requested datasets and a roadmap
that describes the organization of the files on the CD-
ROMs. In the case of some meta-studies, only portions of
the data may be released. A minimal charge is incurred for
the processing and mailing. At the discretion of NIDDK,
charges can be waived.
Discussion
The NIDDK Data Repository discussed here has some
unique and innovative features. The effort in NIDDK for
the creation of central repositories is still relatively
uncommon among NIH funded research. In addition to
establishing a mechanism for the retrieval of legacy data
and samples from completed studies, the interaction
between the central repositories and new studies facili-
tates future availability of scientific resources.
The information the Data Repository provides is much
more than just the clinical results. Value-added work by
the Data Repository staff results in the creation of mean-
ingful catalogues of the available data in order to help the
researchers determine the utility of the data for their own
use. The categorization of data to provide information
such as the number of men over 50 which have end-stage
renal disease across multiple studies, provide researchers
with a head-start in determining which meta-analyses
across datasets might be performed.
Another unique feature of the Data Repository is the inter-
action provided between repository staff and users
requesting data. Where predominantly databases provide
data with little or no human interaction with the user
(e.g., web searches), the Data Repository was designed
from the start to facilitate interaction of staff and the
researchers requesting data. Staff members who are
knowledgeable of the studies and the format of the data
interact with users at the beginning of the data request
process to ensure that the user's needs are met with the
available data and that the users have a good understand-
Data Request Process Figure 2
Data Request Process.BMC Medical Informatics and Decision Making 2006, 6:19 http://www.biomedcentral.com/1472-6947/6/19
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ing of the data formats. Thus, a situation where a user
might receive a large number of SAS data files with little
more documentation than a list of variable names is pre-
cluded. The goal of the Data Repository is to provide as
much assistance as necessary for researchers to perform
their analyses as efficiently as possible.
In addition to data centralization and user support, the
quality control aspect of the Data Repository is a primary
feature to this resource. The analysis of data in order to
reproduce the findings of the clinical studies (where pos-
sible) provides both a check to the accuracy of receipt and
completeness of the data. This process also increases the
understanding of each dataset at the Data Repository and
ultimately results in a more valuable and informed inter-
action with the users. Users of the Data Repository are
asked to provide feedback on the value of the services and
this information is relayed to NIDDK.
Finally, the leadership role of the Data Repository in the
coordination of a biospecimen collection with clinical
data provides an early check in collection process to make
certain that data and samples are unambiguously related.
In doing so, the Data Repository provides to the clinical
studies software tools to track the processing of the sam-
ples at the other repositories and their identifiers within
the LIMS of the sample repositories for their own use.
Sample requests
In addition to providing concordance between biosam-
ples and clinical data, the Data Repository acts as the cen-
tral processing point for DNA and biospecimen requests.
Because of limitations in the amount of sample available,
requests for biospecimens are rigorously reviewed. Infor-
mation needed from a researcher requesting samples
include a synopsis of the research to be performed, study
design, sample management (security) plan, IRB clear-
ance, and data release agreement.
The proposal must state a specific date that an electronic
copy of analysis data derived from the received samples is
expected to be provided to the NIDDK Central Repositor-
ies. The timeframe can be no longer than one year after
receipt of samples or upon publication of research in
which such data were analyzed, whichever comes first,
and annually until the project is completed. The proposal
must also state a specific date that the received data are
expected to be returned or destroyed. The timeframe can
be no longer than 5 years from receipt of the data. Excep-
tions to the research deadline can be submitted to the
repository project officers.
The requestor must submit an IRB clearance or waiver
before samples (and associated data) will be released. A
copy of the human subjects approval must be attached to
the form. An annual human subjects review is required
and must be forwarded to maintain eligibility to use the
samples.
Since requests require that samples of a particular class of
subjects (e.g., patients who responded to a particular treat-
ment), the Data Repository staff work with the requestors
to determine sample availability. In some cases this may
require samples from subjects of different studies, and
staff work with requestors to insure that the samples meet
their research objectives.
This information is reviewed both by NIDDK staff and a
peer-review committee prior to the approval for sample
release. The review process also insures that informed con-
sent for the sample release for that particular purpose is in
compliance. In general, samples are provided free of
charge. The targeted turn-around time for the approval of
such requests is two weeks.
Conclusion
We present here a unique resource for the dissemination
of clinical trial data for studies supported by the NIDDK.
This resource is growing as new datasets are released and
processed for inclusion. The Data Repository provides for
the central dissemination, "one-stop-shopping," for clini-
cal data. Moreover, the data validation which occurs dur-
ing the processing stages helps ensure the accuracy and
quality of the datasets. Sample requests are processed by
the Data Repository as well.
The Data Repository also provides a service both to ongo-
ing clinical studies and the Biosamples and Genetic
(DNA) Repositories. This service includes the assignment
of unique site identifiers to ongoing studies and maintain-
ing the linkage between patient data and collected sam-
ples.
The success of this resource may set an example to other
agencies on the value of providing centralized clinical
results and cataloguing available biospecimens during
ongoing trials.
Availability and requirements
The NIDDK Data Repository is freely available for aca-
demic and commercial users at http://www.NIDDKrepos
itory.org. Release of datasets requires approval of NIDDK
and the signing of a data use agreement due to the anon-
ymous health information in the records. All comments,
suggestions, corrections, and additions, should be sent to
NIDDKadmin@rti.org.
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